First National Trust’s Annovis Bio ANVS Stock Holding History

First National Trust’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$112K	Buy	60,000 +20,000	+50%	+$38.9K	﹤0.01%	373
2026 Q1	$89.2K	Hold	40,000	–	–	﹤0.01%	399
2025 Q4	$138K	Buy	40,000 +25,000	+167%	+$75.1K	﹤0.01%	395
2025 Q3	$31.1K	Hold	15,000	–	–	﹤0.01%	396
2025 Q2	$32.5K	Hold	15,000	–	–	﹤0.01%	381
2025 Q1	$22.5K	Buy	+15,000	New	+$45.9K	﹤0.01%	377

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

First National Trust's ANVS Position: Q2 2026 in Review

First National Trust increased its Annovis Bio (ANVS) stake by 50% in Q2 2026, buying an estimated $38.9K and bringing the position to 60,000 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #373.

First National Trust first reported a position in ANVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $138K in Q4 2025. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

First National Trust held 60,000 shares of Annovis Bio worth $112K as of Q2 2026.
First National Trust bought 20,000 Annovis Bio shares in Q2 2026, an estimated $38.9K.
Annovis Bio made up ﹤0.01% of First National Trust's portfolio in Q2 2026, its #373 holding.
First National Trust first reported a position in Annovis Bio in Q1 2025 and has held it in 6 quarters since.
First National Trust's Annovis Bio position peaked at $138K in Q4 2025.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on First National Trust's 13F filing for Q2 2026, filed 30 Jul 2026.